Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionHoyleCohen, LLC
Latest Disclosed Ownership20,300 shares
Latest Disclosed Value $ 1,392,788
HoyleCohen, LLC reports 2.89% decrease in ownership of GILD / Gilead Sciences, Inc.

On July 19, 2024 - HoyleCohen, LLC filed a 13F-HR form disclosing ownership of 20,300 shares of Gilead Sciences, Inc. (US:GILD) valued at $1,392,783 USD as of June 30, 2024. The entity filed a previous 13F-HR on May 15, 2024 disclosing 20,905 shares of Gilead Sciences, Inc.. This represents a change in shares of -2.89% during the quarter. The current value of the position is $2,621,948 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-07-19 2024-06-30 13F GILEAD SCIENCES COM 375558103 20,300 -605 -2.89 1,393 -9.08 0.1054
2024-05-15 2024-03-31 13F GILEAD SCIENCES COM 375558103 20,905 -1,925 -8.43 1,531 -17.20 0.1168
2024-02-09 2023-12-31 13F GILEAD SCIENCES COM 375558103 22,830 327 1.45 1,849 9.67 0.1511
2023-11-02 2023-09-30 13F GILEAD SCIENCES COM 375558103 22,503 -70 -0.31 1,686 -3.05 0.1564
2023-08-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 22,573 25 0.11 1,740 -7.01 0.1535
2023-05-05 2023-03-31 13F GILEAD SCIENCES COM 375558103 22,548 -422 -1.84 1,871 -5.12 0.1746
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 22,970 -1,188 -4.92 1,972 32.28 0.1963
2022-11-02 2022-09-30 13F GILEAD SCIENCES COM 375558103 24,158 -28,843 -54.42 1,490 -54.52 0.1631
2022-07-27 2022-06-30 13F GILEAD SCIENCES COM 375558103 53,001 -2,325 -4.20 3,276 -0.40 0.3411
2022-05-03 2022-03-31 13F GILEAD SCIENCES COM 375558103 55,326 -8,304 -13.05 3,289 -28.81 0.2816
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 63,630 -3,948 -5.84 4,620 -2.12 0.3841
2021-11-10 2021-09-30 13F GILEAD SCIENCES COM 375558103 67,578 -4,547 -6.30 4,720 -4.97 0.4481
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 72,125 -1,373 -1.87 4,967 4.57 0.3866
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 73,498 -212 -0.29 4,750 10.62 0.4832
2021-02-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 73,710 -1,455 -1.94 4,294 -9.60 0.4954
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 75,165 -1,921 -2.49 4,750 -19.91 0.6987
2020-07-29 2020-06-30 13F GILEAD SCIENCES COM 375558103 77,086 -1,633 -2.07 5,931 0.78 0.9916
2020-05-08 2020-03-31 13F GILEAD SCIENCES COM 375558103 78,719 -1,606 -2.00 5,885 12.74 1.1741
2020-02-10 2019-12-31 13F GILEAD SCIENCES COM 375558103 80,325 -3,245 -3.88 5,220 -1.45 0.8295
2019-11-15 2019-09-30 13F GILEAD SCIENCES COM 375558103 83,570 -395 -0.47 5,297 -6.63 0.9035
2019-08-09 2019-06-30 13F GILEAD SCIENCES COM 375558103 83,965 350 0.42 5,673 4.36 0.9848
2019-05-13 2019-03-31 13F GILEAD SCIENCES COM 375558103 83,615 -1,685 -1.98 5,436 1.87 0.9586
2019-02-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 85,300 -2,142 -2.45 5,336 -20.96 1.0907
2018-11-09 2018-09-30 13F GILEAD SCIENCES COM 375558103 87,442 877 1.01 6,751 10.09 1.2734
2018-08-06 2018-06-30 13F GILEAD SCIENCES COM 375558103 86,565 -1,142 -1.30 6,132 -7.26 1.2367
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 87,707 1,133 1.31 6,612 6.61 1.3411
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 86,574 86,574 6,202 1.2253
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.